Volume 21 - Issue 12 - December 2013
Cover Story
12/16/2013
A look at this year’s clinically relevant discoveries and significant advances in the field of dermatology. The year 2013 has brought many exciting advances in the field of dermatology, particularly in the realm of biologic drugs and in...
A look at this year’s clinically relevant discoveries and significant advances in the field of dermatology. The year 2013 has brought many exciting advances in the field of dermatology, particularly in the realm of biologic drugs and in...
A look at this year’s clinically...
12/16/2013
The Dermatologist
12/16/2013
Rhinosporidiosis is a chronic, granulomatous mucous membrane infection presenting most commonly as a polyploid mass of the nasal, oral, ocular or genital mucosa.1 The taxonomy of the etiologic agent responsible for the disease has been...
Rhinosporidiosis is a chronic, granulomatous mucous membrane infection presenting most commonly as a polyploid mass of the nasal, oral, ocular or genital mucosa.1 The taxonomy of the etiologic agent responsible for the disease has been...
Rhinosporidiosis is a chronic,...
12/16/2013
The Dermatologist
12/16/2013
The tumor necrosis factor (TNF) inhibitors infliximab (Remicade), adalimumab (Humira), etanercept (Enbrel), golimumab (Simponi) and certolizumab pegol (Cimzia) as well as the anti-interleukin (IL)-12/23 monoclonal antibody ustekinumab...
The tumor necrosis factor (TNF) inhibitors infliximab (Remicade), adalimumab (Humira), etanercept (Enbrel), golimumab (Simponi) and certolizumab pegol (Cimzia) as well as the anti-interleukin (IL)-12/23 monoclonal antibody ustekinumab...
The tumor necrosis factor (TNF)...
12/16/2013
The Dermatologist
Legal Ease
12/16/2013
People believe and remember what they see much more than what they read or even hear. Studies have shown that patients recall more data if given pamphlets and pictures than if not given these visual aids.1,2 Imagine if we could show patients...
People believe and remember what they see much more than what they read or even hear. Studies have shown that patients recall more data if given pamphlets and pictures than if not given these visual aids.1,2 Imagine if we could show patients...
People believe and remember what...
12/16/2013
The Dermatologist
Research in Review
12/16/2013
The ubiquity of laser therapy in medicine has allowed for the broad treatment of skin disorders with light-based treatments. In the past, scar revision was often relegated to surgical treatment, whereas current standards allow for more...
The ubiquity of laser therapy in medicine has allowed for the broad treatment of skin disorders with light-based treatments. In the past, scar revision was often relegated to surgical treatment, whereas current standards allow for more...
The ubiquity of laser therapy in...
12/16/2013
The Dermatologist
Spotlight
12/16/2013
Dr. Unger is a clinical professor of dermatology and director of the fellowship program in hair restoration surgery at Mt. Sinai School of Medicine in New York City. He has private practices in Toronto and New York City.
In...
Dr. Unger is a clinical professor of dermatology and director of the fellowship program in hair restoration surgery at Mt. Sinai School of Medicine in New York City. He has private practices in Toronto and New York City.
In...
Dr. Unger is a clinical...
12/16/2013
The Dermatologist
News
12/16/2013
Luliconazole Cream, 1% (Luzu Cream, 1%, Valeant Pharmaceuticals International) received FDA approval for the topical treatment of interdigital tinea pedis, tinea cruris and tinea corporis, caused by the organisms Trichophyton rubrum and...
Luliconazole Cream, 1% (Luzu Cream, 1%, Valeant Pharmaceuticals International) received FDA approval for the topical treatment of interdigital tinea pedis, tinea cruris and tinea corporis, caused by the organisms Trichophyton rubrum and...
Luliconazole Cream, 1% (Luzu...
12/16/2013
The Dermatologist
Chief Medical Editor Message
12/16/2013
Be sure to grab some eggnog and sit down with this month’s issue to peruse the 2013 Year in Review article, in which Jacqueline De Luca highlights some milestone dermatology advances for the year (p. 24). Also don’t miss Part 2 of The Rare...
Be sure to grab some eggnog and sit down with this month’s issue to peruse the 2013 Year in Review article, in which Jacqueline De Luca highlights some milestone dermatology advances for the year (p. 24). Also don’t miss Part 2 of The Rare...
Be sure to grab some eggnog and...
12/16/2013
The Dermatologist
Chief Medical Editor Message
12/16/2013
There’s good reason to think the future is not going to feel any better than the present, and not just because of the ongoing bureaucratization and industrialization of American medical care.
Gross domestic product (GDP) per capita has...
There’s good reason to think the future is not going to feel any better than the present, and not just because of the ongoing bureaucratization and industrialization of American medical care.
Gross domestic product (GDP) per capita has...
There’s good reason to think the...
12/16/2013
The Dermatologist
Research in Review
12/16/2013
Just one month after her husband Steve’s melanoma diagnosis in January 2012, Jennifer Martin clicked open her browser and started her blog, www.martinfamilyjourney.blogspot.com. In the process, she has put a face on a patient’s...
Just one month after her husband Steve’s melanoma diagnosis in January 2012, Jennifer Martin clicked open her browser and started her blog, www.martinfamilyjourney.blogspot.com. In the process, she has put a face on a patient’s...
Just one month...
12/16/2013
The Dermatologist
Derm Dx
12/16/2013
A 14-year-old previously healthy male on no prior medications presented with a generalized eruption that he had for 2 weeks.
A 14-year-old previously healthy male on no prior medications presented with a generalized eruption that he had for 2 weeks.
A 14-year-old previously healthy...
12/16/2013
The Dermatologist
